Correlation Between Effector Therapeutics and Histogen
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Histogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Histogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Histogen, you can compare the effects of market volatilities on Effector Therapeutics and Histogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Histogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Histogen.
Diversification Opportunities for Effector Therapeutics and Histogen
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Effector and Histogen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Histogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Histogen and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Histogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Histogen has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Histogen go up and down completely randomly.
Pair Corralation between Effector Therapeutics and Histogen
If you would invest 2.70 in Histogen on November 28, 2024 and sell it today you would earn a total of 0.00 from holding Histogen or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Effector Therapeutics vs. Histogen
Performance |
Timeline |
Effector Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Histogen |
Risk-Adjusted Performance
OK
Weak | Strong |
Effector Therapeutics and Histogen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Effector Therapeutics and Histogen
The main advantage of trading using opposite Effector Therapeutics and Histogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Histogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will offset losses from the drop in Histogen's long position.Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Histogen vs. Virax Biolabs Group | Histogen vs. Artelo Biosciences | Histogen vs. Curis Inc | Histogen vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |